Is Maze Runner: The Death Cure a Hit or Flop? Official Box Office Record & Profit Analysis
The official verdict is out. With a worldwide gross of $288.2M, Maze Runner: The Death Cure is declared a Blockbuster.
Box Office Snapshot
Detailed Verdict Analysis
Detailed Financial Report
Maze Runner: The Death Cure, released in 2018, entered the cinematic marketplace as a Science Fiction / Action / Adventure / Thriller film. The production path for this project involved significant capital, with a reported budget of approximately $62.0M. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.
Collection Trajectory
The box office journey for Maze Runner: The Death Cure has culminated in a worldwide gross of approximately $288.2M. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of 365%. The numbers reflect a powerful connection with audiences, translating into a box office run that exceeded initial studio projections.
Profitability & Verdict
Analyzing the multiplier effect and market sentiment, Maze Runner: The Death Cure navigated the competitive landscape with an audience reception score of 7.1/10. When weighing the production costs against the global returns, Maze Runner: The Death Cure is effectively categorized as a Blockbuster. It stands as a testament to the power of high-concept storytelling and broad audience appeal.
Comparables
In the context of other Science Fiction releases, the performance of Maze Runner: The Death Cure will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 2018 box office narrative.
Audience Reception
Apart from the financial numbers, the audience sentiment plays a crucial role. Not all box office hits are loved, and not all flops are bad movies.